Adjuvant low-dose rituximab and plasma exchange for acquired TTP-Reference-Cited by-同舟云学术

Adjuvant low-dose rituximab and plasma exchange for acquired TTP

Published:2019-07-22 Issue:13 Volume:134 Page:1106-1109
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Zwicker Jeffrey I.¹^ORCID,Muia Joshua²^ORCID,Dolatshahi Leili³,Westfield Lisa A.²,Nieters Patricia⁴,Rodrigues Anita¹,Hamdan Ayad¹,Antun Ana G.⁵,Metjian Ara⁶,Sadler J. Evan²⁷^ORCID

Affiliation:

1. Division of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA;

2. Department of Medicine, Washington University School of Medicine, St. Louis, MO;

3. Division of Pediatric Hematology, Saint Louis University School of Medicine, St. Louis, MO;

4. Washington University Institute of Clinical and Translational Sciences, Washington University School of Medicine, St. Louis, MO;

5. Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA;

6. Division of Hematology, Duke University School of Medicine, Durham, NC; and

7. Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/134/13/1106/1222958/bloodbld2019000795.pdf

Reference15 articles.

1. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura;Rock;N Engl J Med,1991

2. Survival and relapse in patients with thrombotic thrombocytopenic purpura;Kremer Hovinga;Blood,2010

3. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura;Sadler;Blood,2008

4. A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura;Scully;Blood,2011

5. Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse;Westwood;J Thromb Haemost,2013

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons;Expert Review of Hematology;2024-02-20

2. Hämatologische und onkologische Notfälle;Springer Reference Medizin;2024

3. Thrombotic thrombocytopenic purpura;The Rose and Mackay Textbook of Autoimmune Diseases;2024

4. Cattle-FRETS71, a novel fluorogenic substrate with broad applicability for characterizing ADAMTS13 properties and function;Journal of Thrombosis and Haemostasis;2023-12

5. Recent Advances in the Management of Microangiopathic Hemolytic Anemias (MAHA): A Narrative Review;Cureus;2023-10-17